Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARES: Peginterferon alpha-2a add-on to entecavir in HBeAg-positive chronic hepatitis B
2008-006239-11Phase 4Active
- Sponsor
- Stichting Leveronderzoek
- Start
- Jan 2009
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of entecavir and interferon alfa in Chronic Hepatitis B (CHB) (2 arms), sponsored by Stichting Leveronderzoek. Primary endpoint: Primary outcome (response). Started Jan 2009; status: active.
02
Drugs
entecavirinterferon alfa
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2008-006239-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006239-11.